title: Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections.
abstract: This study aimed to assess the prevalence of bacterial vaginosis (BV) and other cervicovaginal infections, as well as the incidence of complications among new users of IUD, 1 and 6 months after its insertion, in the City of Campinas, Brazil. A total of 223 women who had a TCu-380A IUD inserted from May through November 2001, were included in the study. After the IUD insertion all women were scheduled to two additional visits: after 1 month and after 6 months, when they were interviewed and a pelvic examination was performed, along with a collection of specimens from the vagina and the endocervix for laboratory testing. The Nugent's criterion was used for the BV diagnosis. They were also evaluated with regard to presence of complications possibly related to IUD insertion and use, i.e., abnormal bleeding, dysmenorrhea, expulsion and pelvic inflammatory disease. The prevalence of cervicovaginal infections was 29.1%, BV being the most frequent (19.7%). Dysmenorrhea was more frequent among women with BV than among women without BV (p = 0.03). A trend of abnormal bleeding being more frequent among women with BV was also found. In conclusion, BV after 1 month of IUD insertion was not associated with IUD complications, with the exception of dysmenorrhea.
authors.affiliation: Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas, 13084-971 Campinas, Brazil.
authors.forename: Raquel
authors.initials: R
authors.lastname: Ferraz do Lago
authors.forename: Jose A
authors.initials: JA
authors.lastname: Simões
authors.forename: Luis
authors.initials: L
authors.lastname: Bahamondes
authors.forename: Rodrigo P S
authors.initials: RP
authors.lastname: Camargo
authors.forename: Marcos
authors.initials: M
authors.lastname: Perrotti
authors.forename: Ilza
authors.initials: I
authors.lastname: Monteiro
mesh_terms: D000293:Adolescent; D000328:Adult; D001938:Brazil / Q000453:epidemiology; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000453:epidemiology / Q000209:etiology; D002690:Chlamydia Infections / Q000453:epidemiology / Q000209:etiology*; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007434:Intrauterine Devices / Q000009:adverse effects*; D015995:Prevalence; D002577:Uterine Cervical Diseases / Q000453:epidemiology / Q000209:etiology*; D014623:Vaginal Diseases / Q000453:epidemiology / Q000209:etiology*; D016585:Vaginosis, Bacterial / Q000453:epidemiology / Q000209:etiology